
Biopharmaceutical Product Development Group manages all processes from the discovery of recombinant proteins, monoclonal antibodies, and biotechnological products to preclinical development. The group designs innovative therapeutic strategies using molecular modeling, diagnostic kits, and delivery systems, while rigorously evaluating drug efficacy and safety. This interdisciplinary approach forms a strong bridge between basic science and translational medicine.